Evidence map›Paper›PMID 35011455›Full record

ArticleMolecules (Basel, Switzerland)2021

Biosynthesis of Silver Chloride Nanoparticles by Rhizospheric Bacteria and Their Antibacterial Activity against Phytopathogenic Bacterium

Iman Sabah Abd Alamer, Ali Athafah Tomah, Temoor Ahmed, Bin Li, Jingze Zhang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Selenium/Zinc nanocomposite (Se/Zn NC) bioengineered byThe Libyan journal of medicine · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Applications of silver nanoparticles synthesized fromBiotechnology notes (Amsterdam, Netherlands) · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Green Extracellular Synthesis of Silver Nanoparticles byMolecules (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Iman Sabah Abd AlamerState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-2319-0711
Ali Athafah TomahState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-9186-3367
Temoor AhmedState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, Hangzhou 310058, China.
Bin LiState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-4581-4775
Jingze ZhangState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0001-8604-8280

Funding

Key Science and Technology Project of Zhejiang Province 2015C02023National Natural Science Foundation of China 31501342Special Fund for Agro-scientific Research in the Public Interest of China 201503109
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Metal NanoparticlesRhizosphereAnti-Bacterial AgentsAntibiosisBacteriaLipopeptidesMicrobial Sensitivity TestsPlant DiseasesRalstonia solanacearumSilver CompoundsSpectrum AnalysisAnti-Bacterial AgentsLipopeptidessilver chlorideSilver Compoundsantibacterial activityBacillus mojavensismolecular interactionRalstonia solanacearumtaxonomy

Identifiers

PMID35011455
PMCPMC8746595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.